Literature DB >> 24422098

Tumour cells coerce host tissue to cancer spread.

Ilaria Malanchi1.   

Abstract

A solid tumour is a complex structure and understanding this complexity is required to study the disease progression. Indeed, 90% of cancer deaths are due to metastatic spreading. Two aspects contribute to tumour complexity. One is the synergistic relationship between tumour cells and their associated host tissue, which persistently characterize tumour growth from the onset to metastasis. Another aspect is the heterogeneity of the cancer cells. It is now clear that within a tumour mass there is a hierarchical organization, stemming from a small amount of cells retaining the highest tumorigenic potential, named cancer stem cells (CSCs). Despite being one of the main studied topics in cancer research, CSC definition is still the subject of debate. Functional testing allows their identification, which is the ability of recapitulating the original tumour structure when transplanted in mice, but occasionally generates conflicting results. This has shaped the hypothesis that their key initiation ability is conditioned by their local microenvironment called niche. The CSC identity appears to be a contextual status where the ability to create a favourable supporting microenvironment may become a key hallmark of their tumour initiation capability. Remarkably, as shown in experimental models, the tumour-initiating potential of CSCs is maintained during metastatic progression, when disseminated cancer cells require the creation of their permissive niche to be able to trigger metastatic growth. This review will discuss the most recent findings on metastatic niche establishment and the cooperation between cancer cells and their newly recruited tumour-associated stroma forming the basis of metastatic development.

Entities:  

Year:  2013        PMID: 24422098      PMCID: PMC3817981          DOI: 10.1038/bonekey.2013.105

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  50 in total

1.  Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.

Authors:  Bing Hu; Einar Castillo; Louise Harewood; Paola Ostano; Alexandre Reymond; Reinhard Dummer; Wassim Raffoul; Wolfram Hoetzenecker; Günther F L Hofbauer; G Paolo Dotto
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

Review 3.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

Review 4.  Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization.

Authors:  Neta Erez; Lisa M Coussens
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

5.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.

Authors:  Mélanie Bruchard; Grégoire Mignot; Valentin Derangère; Fanny Chalmin; Angélique Chevriaux; Frédérique Végran; Wilfrid Boireau; Benoit Simon; Bernhard Ryffel; Jean Louis Connat; Jean Kanellopoulos; François Martin; Cédric Rébé; Lionel Apetoh; François Ghiringhelli
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

8.  Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C.

Authors:  Emmanuel Garcion; Aida Halilagic; Andreas Faissner; Charles ffrench-Constant
Journal:  Development       Date:  2004-07       Impact factor: 6.868

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466

View more
  9 in total

1.  Colorectal cancer prognosis and PPARδ/β expression in the tumor microenvironment.

Authors:  Gianluigi Mazzoccoli
Journal:  J Gastroenterol       Date:  2013-11-26       Impact factor: 7.527

2.  Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.

Authors:  Norashikin Zakaria; Narazah Mohd Yusoff; Zubaidah Zakaria; Moon Nian Lim; Puteri J Noor Baharuddin; Kamal Shaik Fakiruddin; Badrul Yahaya
Journal:  BMC Cancer       Date:  2015-02-25       Impact factor: 4.430

3.  Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop.

Authors:  Shravanti Mukherjee; Minakshi Mazumdar; Samik Chakraborty; Argha Manna; Shilpi Saha; Poulami Khan; Pushpak Bhattacharjee; Deblina Guha; Arghya Adhikary; Sanhita Mukhjerjee; Tanya Das
Journal:  Stem Cell Res Ther       Date:  2014-10-14       Impact factor: 6.832

4.  A primary tumor gene expression signature identifies a crucial role played by tumor stroma myofibroblasts in lymph node involvement in oral squamous cell carcinoma.

Authors:  Tommaso Mazza; Lorenzo Lo Muzio; Gianluigi Mazzoccoli; Stefano Castellana; Massimo Carella; Orazio Palumbo; Cristiana Tiberio; Caterina Fusilli; Daniele Capocefalo; Tommaso Biagini
Journal:  Oncotarget       Date:  2017-09-05

Review 5.  Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.

Authors:  Ilaria Roato; Riccardo Ferracini
Journal:  Cancers (Basel)       Date:  2018-02-20       Impact factor: 6.639

6.  Prediction on the inhibition ratio of pyrrolidine derivatives on matrix metalloproteinase based on gene expression programming.

Authors:  Yuqin Li; Guirong You; Baoxiu Jia; Hongzong Si; Xiaojun Yao
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

7.  Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization.

Authors:  Yaiza Del Pozo Martin; Danielle Park; Anassuya Ramachandran; Luigi Ombrato; Fernando Calvo; Probir Chakravarty; Bradley Spencer-Dene; Stefanie Derzsi; Caroline S Hill; Erik Sahai; Ilaria Malanchi
Journal:  Cell Rep       Date:  2015-12-06       Impact factor: 9.423

Review 8.  Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives.

Authors:  Yousef M Hawsawi; Faisal Al-Zahrani; Charalampos Harris Mavromatis; Mohammed A Baghdadi; Shalini Saggu; Atif Abdulwahab A Oyouni
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 9.  The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome-A Review.

Authors:  Sara Sofia Deville; Nils Cordes
Journal:  Front Oncol       Date:  2019-12-06       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.